Abstract:Chronic low-grade inflammation is a central component in the pathogenesis of obesity-related expansion of adipose tissue and complications in other metabolic tissues. Five different signaling pathways are defined as dominant determinants of adipose tissue inflammation: These are increased circulating endotoxin due to dysregulation in the microbiota-gut-brain axis, systemic oxidative stress, macrophage accumulation, and adipocyte death. Finally, the nucleotide-binding and oligomerization domain (NOD) leucine-rich repeat family pyrin domain-containing 3 (NLRP3) inflammasome pathway is noted to be a key regulator of metabolic inflammation. The NLRP3 inflammasome and associated metabolic inflammation play an important role in the relationships among fatty acids and obesity. Several highly active molecules, including primarily leptin, resistin, adiponectin, visfatin, and classical cytokines, are abundantly released from adipocytes. The most important cytokines that are released by inflammatory cells infiltrating obese adipose tissue are tumor necrosis factor-alpha (TNF-α), interleukin 6 (IL-6), monocyte chemoattractant protein 1 (MCP-1) (CCL-2), and IL-1. All these molecules mentioned above act on immune cells, causing local and then general inflammation. Three metabolic pathways are noteworthy in the development of adipose tissue inflammation: toll-like receptor 4 (TLR4)/phosphatidylinositol-3'-kinase (PI3K)/Protein kinase B (Akt) signaling pathway, endoplasmic reticulum (ER) stress-derived unfolded protein response (UPR), and inhibitor of nuclear factor kappa-B kinase beta (IKKβ)-nuclear factor kappa B (NF-κB) pathway. In fact, adipose tissue inflammation is an adaptive response that contributes to a visceral depot barrier that effectively filters gut-derived endotoxin. Excessive fatty acid release worsens adipose tissue inflammation and contributes to insulin resistance. However, suppression of adipose inflammation in obesity with anti-inflammatory drugs is not a rational solution and paradoxically promotes insulin resistance, despite beneficial effects on weight gain. Inflammatory pathways in adipocytes are indeed indispensable for maintaining systemic insulin sensitivity. Cannabinoid type 1 receptor (CB1R) is important in obesity-induced pro-inflammatory response; however, blockade of CB1R, contrary to anti-inflammatory drugs, breaks the links between insulin resistance and adipose tissue inflammation. Obesity, however, could be decreased by improving leptin signaling, white adipose tissue browning, gut microbiota interactions, and alleviating inflammation. Furthermore, capsaicin synthesized by chilies is thought to be a new and promising therapeutic option in obesity, as it prevents metabolic endotoxemia and systemic chronic low-grade inflammation caused by high-fat diet.

Obesity and chronic inflammation in adipose tissue

Sphingosine-1-phosphate and obesity-induced inflammation

Chronic Adipose Tissue Inflammation Linking Obesity to Insulin Resistance and Type 2 Diabetes

Adipose Tissue Vascularization: Its Role in Chronic Inflammation

Obesity:an Inflammatory Disease

Pathogenesis Progress of Obesity Environment in Promoting Adipose Tissue Fibrosis

Inflammation‐mediated metabolic regulation in adipose tissue

Inflammation-a common denominator in obesity and insulin resistance

&Lt;p>saturated Fatty Acids in Obesity-Associated Inflammation</p>

Obese visceral fat tissue inflammation: from protective to detrimental?

Adipocytes properties and crosstalk with immune system in obesity‐related inflammation

Adipose Tissue Inflammation and Metabolic Dysfunction in Obesity.

Chronic Inflammation in Obesity and the Metabolic Syndrome

Obesity and inflammation: the linking mechanism and the complications

Reappraisal of Adipose Tissue Inflammation in Obesity

CD36: the Common Soil for Inflammation in Obesity and Atherosclerosis?

Endothelial Dysfunction in Obesity-Induced Inflammation: Molecular Mechanisms and Clinical Implications

Inflamed adipose tissue: A culprit underlying obesity and heart failure with preserved ejection fraction

Adipocyte promotes adipose tissue inflammation and insulin resistance by modulating macrophages in obesity

Tissue Immune Cells Fuel Obesity-Associated Inflammation in Adipose Tissue and Beyond

Orchestration of the Adipose Tissue Immune Landscape by Adipocytes